You need more than management consulting. You need the right team.

Get what it takes to perform at the leading edge of life sciences. Make our people your people.

See How

From startups to global organizations, we have your solutions.

Halloran has the people to get you where you need to go.

Hands-On Solutions

When you’re starting a biotech or device program, everything is urgent. The pace is demanding, the challenges intimidating, and decisions have far-reaching implications.

Learn More

Organizational Solutions

Functioning in an organization spanning international borders and clinical regulatory environments means overcoming obstacles, and doing so inside the boundaries of the big picture.

Learn More

Measure for Measure

Featured Post from Our Thinking

Published in Clinical Researcher. A wonderful scene in the film Dead Poets’ Society shows an English teacher leading his class through a textbook exercise to assess the quality of a poem: "To fully understand poetry we must first be fluent with its meter, rhyme, and figures of speech. Then ask two questions: One, how artfully has the subject of the poem been rendered, and two, how important is that objective? …. If the poem’s score for perfection is plotted on the horizontal of a graph, and its importance is plotted on the vertical, then calculating the total area of a poem yields the measure of its greatness. The students scribble notes furiously until the teacher pronounces the method bogus and encourages them to rip the offending pages from their books." As a graduate student in English when this movie debuted, I understood this scene as a jab at the formalist school of literary criticism. Now that I work in clinical development, it seems emblematic of our approach to clinical metrics: We ask the wrong questions and end up with data we can’t use. This article considers the causes and consequences of this phenomenon, and suggests some remedies. Points to Ponder How did we get to this point? Like the author of the textbook the English teacher dismisses in the film, we are beholden to an outmoded idea: the balanced scorecard. Popularized by a 1992 article in the Harvard Business Review, the scorecard’s architects encouraged managers to “balance”...

Read More » View All Articles

Upcoming Events

  • Sep042015
    ACRP Advanced GCP: Assessing Compliance Risk

    Please join Halloran when Senior Consultant, Lydia Dyett, teaches a full-day course with the Association of Clinical Research Professionals on…

    Read More »
  • Sep172015
    Outsourcing In Clinical Trials New England 2015

    Join Halloran at Outsourcing in Clinical Trials New England on September 16-17, 2015 in Boston, MA where Halloran President and CEO, Laurie…

    Read More »
  • Sep232015
    MassDevice DeviceTalks 2015 – St. Paul

    Halloran is pleased to participate in MassDevice's DeviceTalks on September 23, 2015 in St. Paul, MN. DeviceTalks, the live interview…

    Read More »
View All Events

Find the best solutions for you.

Overcoming FDA clinical regulatory hurdles, diagnosing organizational dysfunction, addressing quality issues, adverse event preparedness, evaluating potential investments, or even just filling in knowledge gaps – all of our capabilities become yours.

Our Services

What Sets Us Apart?

The Best Talent in the Industry.

A company with a culture of great ideas and close collaboration and passion to always do what is right for our clients. We have been assembling the strongest life science consulting team in the business for more than two decades. Attracting the best people is a product of thought leadership, but also of culture.

Meet the Team
  • Regulatory Consulting
  • Halloran Clinical Quality Assurance Consulting team
  • Halloran FDA Audit and SOP Expert Consulting team